TY - JOUR
T1 - Prognostic value of ventricular-arterial coupling after transcatheter aortic valve replacement on midterm clinical outcomes
AU - OCEAN-TAVI Investigators
AU - Yokoyama, Hiroaki
AU - Yamanaka, Futoshi
AU - Shishido, Koki
AU - Ochiai, Tomoki
AU - Yokota, Shohei
AU - Moriyama, Noriaki
AU - Watanabe, Yusuke
AU - Shirai, Shinichi
AU - Tada, Norio
AU - Araki, Motoharu
AU - Yashima, Fumiaki
AU - Naganuma, Toru
AU - Ueno, Hiroshi
AU - Tabata, Minoru
AU - Mizutani, Kazuki
AU - Takagi, Kensuke
AU - Yamamoto, Masanori
AU - Saito, Shigeru
AU - Hayashida, Kentaro
N1 - Publisher Copyright:
© 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2021/9/21
Y1 - 2021/9/21
N2 - BACKGROUND: Ventricular-arterial coupling predicts outcomes in patients with heart failure. The arterial elastance to end-systolic elastance ratio (Ea/Ees) is a noninvasively assessed index that reflects ventricular-arterial coupling. We aimed to determine the prognostic value of ventricular-arterial coupling assessed through Ea/Ees after transcatheter aortic valve replacement to predict clinical events. METHODS AND RESULTS: We retrieved data on 1378 patients (70% women) who underwent transcatheter aortic valve replacement between October 2013 and May 2017 from the OCEAN-TAVI (Optimized transCathEter vAlvular iNtervention) Japanese multicenter registry. We determined the association between Ea/Ees and the composite end point of hospitalization for heart failure and cardiovascular death by classifying the patients into quartiles based on Ea/Ees values (group 1: <0.326; group 2: 0.326– 0.453; group 3: 0.453– 0.666; and group 4: >0.666) during the midterm follow-up after transcatheter aortic valve replacement. During a median follow-up period of 736 days (interquartile range, 414– 956), there were 247 (17.9%) all-cause deaths, 89 (6.5%) cardiovascular deaths, 130 (9.4%) hospitalizations for heart failure, and 199 (14.4%) composite events of hospitalization for heart failure and cardiovascular death. The incidence of the composite end point was significantly higher in group 2 (hazard ratio [HR], 1.76; 95% CI, 1.08– 2.87 [P=0.024]), group 3 (HR, 2.43; 95% CI, 1.53– 3.86 [P<0.001]), and group 4 (HR, 2.89; 95% CI, 1.83– 4.57 [P<0.001]) than that in group 1. On adjusted multivariable Cox analysis, Ea/Ees was significantly associated with composite events (HR, 1.47 per 1-unit increase; 95% CI, 1.08– 2.01 [P=0.015]). CONCLUSIONS: These findings suggest that a higher Ea/Ees at discharge after transcatheter aortic valve replacement is associated with adverse clinical outcomes during midterm follow-up. REGISTRATION: URL: https://www.upload.umin.ac.jp/. Unique identifier: UMIN000020423.
AB - BACKGROUND: Ventricular-arterial coupling predicts outcomes in patients with heart failure. The arterial elastance to end-systolic elastance ratio (Ea/Ees) is a noninvasively assessed index that reflects ventricular-arterial coupling. We aimed to determine the prognostic value of ventricular-arterial coupling assessed through Ea/Ees after transcatheter aortic valve replacement to predict clinical events. METHODS AND RESULTS: We retrieved data on 1378 patients (70% women) who underwent transcatheter aortic valve replacement between October 2013 and May 2017 from the OCEAN-TAVI (Optimized transCathEter vAlvular iNtervention) Japanese multicenter registry. We determined the association between Ea/Ees and the composite end point of hospitalization for heart failure and cardiovascular death by classifying the patients into quartiles based on Ea/Ees values (group 1: <0.326; group 2: 0.326– 0.453; group 3: 0.453– 0.666; and group 4: >0.666) during the midterm follow-up after transcatheter aortic valve replacement. During a median follow-up period of 736 days (interquartile range, 414– 956), there were 247 (17.9%) all-cause deaths, 89 (6.5%) cardiovascular deaths, 130 (9.4%) hospitalizations for heart failure, and 199 (14.4%) composite events of hospitalization for heart failure and cardiovascular death. The incidence of the composite end point was significantly higher in group 2 (hazard ratio [HR], 1.76; 95% CI, 1.08– 2.87 [P=0.024]), group 3 (HR, 2.43; 95% CI, 1.53– 3.86 [P<0.001]), and group 4 (HR, 2.89; 95% CI, 1.83– 4.57 [P<0.001]) than that in group 1. On adjusted multivariable Cox analysis, Ea/Ees was significantly associated with composite events (HR, 1.47 per 1-unit increase; 95% CI, 1.08– 2.01 [P=0.015]). CONCLUSIONS: These findings suggest that a higher Ea/Ees at discharge after transcatheter aortic valve replacement is associated with adverse clinical outcomes during midterm follow-up. REGISTRATION: URL: https://www.upload.umin.ac.jp/. Unique identifier: UMIN000020423.
KW - Heart failure
KW - Transcatheter aortic valve replacement
KW - Ventricular-aortic coupling
UR - https://www.scopus.com/pages/publications/85117279437
U2 - 10.1161/JAHA.120.019267
DO - 10.1161/JAHA.120.019267
M3 - 記事
C2 - 34533038
AN - SCOPUS:85117279437
SN - 2047-9980
VL - 10
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 18
M1 - e019267
ER -